| pubmed-article:9875766 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9875766 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:9875766 | lifeskim:mentions | umls-concept:C0018826 | lld:lifeskim |
| pubmed-article:9875766 | lifeskim:mentions | umls-concept:C0596171 | lld:lifeskim |
| pubmed-article:9875766 | lifeskim:mentions | umls-concept:C0079366 | lld:lifeskim |
| pubmed-article:9875766 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9875766 | pubmed:dateCreated | 1999-2-3 | lld:pubmed |
| pubmed-article:9875766 | pubmed:abstractText | Techniques of tissue engineering are used to seed human autologous cells in vitro on degradable mesh to create new functional tissue like a bioprosthetic heart valve. A precondition is subsequent seeding of native-valve-analogous pure endothelial and myofibroblast cell lines. The aim of this study is to find a safe method of isolating viable cell lines out of tissues from the operating room. | lld:pubmed |
| pubmed-article:9875766 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9875766 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9875766 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9875766 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9875766 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9875766 | pubmed:issn | 0003-4975 | lld:pubmed |
| pubmed-article:9875766 | pubmed:author | pubmed-author:YuAA | lld:pubmed |
| pubmed-article:9875766 | pubmed:author | pubmed-author:VogtP RPR | lld:pubmed |
| pubmed-article:9875766 | pubmed:author | pubmed-author:TuriniM AMA | lld:pubmed |
| pubmed-article:9875766 | pubmed:author | pubmed-author:ZündGG | lld:pubmed |
| pubmed-article:9875766 | pubmed:author | pubmed-author:SchoeberleinA... | lld:pubmed |
| pubmed-article:9875766 | pubmed:author | pubmed-author:HoerstrupS... | lld:pubmed |
| pubmed-article:9875766 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9875766 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:9875766 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9875766 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9875766 | pubmed:pagination | 1653-7 | lld:pubmed |
| pubmed-article:9875766 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:meshHeading | pubmed-meshheading:9875766-... | lld:pubmed |
| pubmed-article:9875766 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9875766 | pubmed:articleTitle | Fluorescence activated cell sorting: a reliable method in tissue engineering of a bioprosthetic heart valve. | lld:pubmed |
| pubmed-article:9875766 | pubmed:affiliation | Department of Cardiovascular Surgery, University Hospital Zürich, Switzerland. | lld:pubmed |
| pubmed-article:9875766 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9875766 | lld:pubmed |
